Close Menu

University of Utah

People in the News

Premium

John Opitz, a medical geneticist at the University of Utah, has been awarded the William Allan Award by the American Society of Human Genetics for his work in identifying and understanding genetic syndromes.

By Justin Petrone
Salt Lake City Bioscience plans to commercialize a new technology platform developed by the University of Utah.

Researchers using exome sequencing to study ADHD found rare mutations they think may be causing a patient's anemia, raising the question of how to handle unrelated findings in sequencing studies.

According to the amended complaint, University of Utah's Brenda Bass had “so well-defined” the concept at issue that it "could have been reduced to practice by someone with ordinary skill in the art without further research.”

Allegro CEO Mike Webb said the licensing agreement will support the "continued advancement" of the firm's BronchoGen test, including a planned commercial launch in the first half of 2012.

Omicia, which co-developed VAAST with Mark Yandell’s group at the University of Utah, is now working on integrating the algorithm into a platform called the Genome Analysis System, which it plans to release commercially at the end of the third quarter.

The IP licensed by Allegro relates to a gene expression-based platform that detects common molecular responses that occur throughout the respiratory tract in current and former smokers with lung cancer.

Brenda Bass “conceived the inventions of all the issued claims of Tuschl-II and at least some pending claims of Tuschl-I well before any date asserted by the currently named inventors,” the University of Utah alleges.

The company is using a quantitative PCR method licensed from the University of Utah to measure telomere length from tissue samples for research, drug-development, and health-monitoring applications.

In the lawsuit, which comes just days after Alnylam said it settled a different suit related to the IP, the University of Utah alleges that one of its researchers actually invented the technology covered by the Tuschl-II patent estate.

Pages

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.